Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash Flows from Operating Activities:
Net income	$ 4,063	$ 4,128
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for loan losses	300	50
Depreciation	444	475
Net accretion of acquisition accounting adjustments	(434)	(1,001)
Core deposit intangible amortization	165	288
Net amortization of securities	542	686
Net gains on sale or call of securities	(259)	(366)
Gain on sale of loans held for sale	(420)	(233)
Proceeds from sales of loans held for sale	22,668	14,131
Originations of loans held for sale	(18,124)	(11,417)
Net loss on other real estate owned	3	50
Valuation allowance on other real estate owned	26	53
Net gain on sale of premises and equipment	0	(1)
Equity based compensation expense	309	244
Earnings on bank owned life insurance	(107)	(115)
Deferred income tax expense (benefit)	438	(1,716)
Net change in interest receivable	601	(592)
Net change in other assets	(350)	883
Net change in interest payable	(49)	8
Net change in other liabilities	250	964
Net cash provided by operating activities	10,066	6,519
Cash Flows from Investing Activities:
Proceeds from sales of securities available for sale	41,519	12,867
Proceeds from maturities, calls and paydowns of securities available for sale	12,885	26,127
Purchases of securities available for sale	0	(54,107)
Net change in restricted stock	732	(43)
Net increase in loans	(55,067)	(28,080)
Proceeds from sale of premises and equipment	0	1
Purchases of premises and equipment	(663)	(149)
Proceeds from sales of other real estate owned	37	685
Net cash used in investing activities	(557)	(42,699)
Cash Flows from Financing Activities:
Net change in demand, money market, and savings deposits	53,087	26,048
Net change in time deposits	(7,623)	3,723
Net change in customer repurchase agreements	8,610	1,573
Net change in other short-term borrowings	(20,000)	0
Common stock dividends paid	(2,073)	(2,065)
Repurchase of common stock	0	(964)
Proceeds from exercise of stock options	73	59
Net cash provided by financing activities	32,074	28,374
Net Increase (Decrease) in Cash and Cash Equivalents	41,583	(7,806)
Cash and Cash Equivalents at Beginning of Period	53,207	95,337
Cash and Cash Equivalents at End of Period	$ 94,790	$ 87,531